2D
2DR.F Inspire Medical Systems Inc
- Market cap
- EUR 1.59B
- P/E
- 18.9x
- P/B
- 2.18x
- ROE
- -5.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 2DR.F undervalued?
Graham number2DR.F trades 35.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Inspire Medical Systems Inc fundamental analysis
No fundamental analysis for Inspire Medical Systems Inc yet.
Inspire Medical Systems Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing…
Full company profileInspire Medical Systems Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Inspire Medical Systems Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 16.4M | 28.6M | 50.6M | 82.1M | 115M | 233M | 408M | 625M | 803M | 912M | 816M |
| Gross Profit | 12.5M | 22.5M | 40.5M | 68.4M | 97.8M | 200M | 342M | 528M | 680M | 779M | 702M |
| Operating Income | -17.3M | -16.0M | -20.4M | -34.9M | -56.2M | -39.9M | -47.6M | -40.3M | 36.1M | 51.0M | -40.5M |
| EBITDA | - | -15.5M | -18.1M | -30.6M | -54.1M | -39.8M | -42.6M | -17.1M | 65.0M | 79.8M | -20.7M |
| Net Income | -18.5M | -17.5M | -21.8M | -33.2M | -57.2M | -42.0M | -44.9M | -21.2M | 53.5M | 145M | -47.2M |
| EPS | - | -1.30 | -0.93 | -1.38 | -2.11 | -1.53 | -1.55 | -0.72 | 1.80 | 5.09 | -1.63 |
| Balance Sheet | |||||||||||
| Total Assets | 13.1M | 25.1M | 200M | 181M | 281M | 295M | 565M | 677M | 808M | 907M | 953M |
| Total Liabilities | 19.7M | 23.6M | 36.1M | 41.4M | 51.4M | 66.0M | 68.9M | 104M | 119M | 126M | 126M |
| Shareholders' Equity | -6.61M | 1.48M | 164M | 140M | 230M | 229M | 496M | 573M | 690M | 781M | 827M |
| Cash & Short-term Investments | 6.69M | 8.96M | 97.3M | 22.9M | 191M | 214M | 442M | 186M | 150M | 105M | 191M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -17.9M | -15.8M | -18.7M | -32.8M | -53.0M | -20.1M | 11.6M | 26.7M | 130M | 117M | 110M |
| Capital Expenditure | 306K | 412K | 250K | 2.74M | 2.46M | 4.67M | 9.10M | 18.5M | 39.1M | 38.5M | 35.2M |
| Free Cash Flow | - | -16.2M | -18.9M | -35.6M | -55.5M | -24.8M | 2.47M | 8.11M | 91.1M | 78.5M | 74.8M |
| Ratios | |||||||||||
| ROE | - | -1,180.0% | -13.3% | -23.8% | -24.9% | -18.4% | -9.0% | -3.7% | 7.8% | 18.6% | -5.7% |
| ROA | -141.3% | -69.8% | -10.9% | -18.3% | -20.3% | -14.2% | -7.9% | -3.1% | 6.6% | 16.0% | -4.9% |
| Net Profit Margin | -112.8% | -61.3% | -43.1% | -40.5% | -49.6% | -18.0% | -11.0% | -3.4% | 6.7% | 15.9% | -5.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Inspire Medical Systems Inc dividends
Inspire Medical Systems Inc has not paid dividends in the last 9 fiscal years.
Who owns Inspire Medical Systems Inc
- Insiders 1.18%
- Institutions 98.82%
- Public & others 0.00%
- Shares outstanding 29.0M
- Free float 25.3M
Inspire Medical Systems Inc company profile
- Company name
- Inspire Medical Systems Inc
- Ticker
- 2DR.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,333
- Fiscal year end
- December
- Address
- 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416
- Phone
- 844 672 4357
- Website
- inspiresleep.com
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems Inc management
10- Mr. Timothy P. HerbertFounder, Chairman, CEO & President · born 1963
- Mr. Bryan K. Phillips J.D.Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary · born 1971
- Mr. Carlton W. WeatherbyChief Strategy and Growth Officer · born 1985
- Mr. Matthew J. OsbergExecutive VP & CFO · born 1977
- Mr. Jason P. KellyChief Operations & Innovation Officer · born 1980
- Ms. Melissa J. MannChief People Officer · born 1976
- Mr. Ivan LubogoSVP of Strategic Sales
- Mr. Andreas HenkeExecutive VP International & MD
- Mr. Joseph E. SanderSenior Vice President of U.S. Sales
- Ms. Megan Rowekamp CPADirector of Financial Reporting